// App-Quantinova.ai

PB0270 : Rivaroxaban for the treatment of thrombosis in pediatric patients with leukemia. Results of a pilot study

Researchers

Presenter

  • S. Rodriguez Miranda

Principal Investigators

  • N/A

Medical Centers

  • Hematology, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, Mexico

  • Universidad Autonoma de Nuevo Leon, Monterrey, Mexico

  • Hospital Universitario "Dr. José Eleuterio González", Monterrey, NL,...

  • CIMAT, Monterrey, Nuevo Leon, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved